<img alt="Vasiprak FNB Pvt Ltd" data-src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-2.svg" class="logo-dark lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-2.svg" alt="Vasiprak FNB Pvt Ltd" class="logo-dark" >

<img alt="Vasiprak FNB Pvt Ltd" data-src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-White-2.svg" class="logo-light lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-White-2.svg" alt="Vasiprak FNB Pvt Ltd" class="logo-light" >

Vasiprak FNB Pvt Ltd

Breaking Boundaries since 2018

Vasiprak Blog

viatris

Biocon Biologics to Acquire Viatris’ Biosimilars Assets, Health News, ET HealthWorld

Bengaluru, India, February 27, 2022 – Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced today that it has entered into a definitive agreement with its partner Viatris Inc. Accordingly,…

Biocon’s interchangeable biosimilar Insulin glargine added on Express Scripts’ largest formulary in US, Health News, ET HealthWorld

Biocon and its partner Viatris said Express Scripts, a leading Pharmacy benefit manager (PBM) Express in US, will be listing interchangeable biosimilar Insulin Glargine sold under brand name Semglee as…